Ritter Pharmaceuticals, Inc.
Records under this name other than patents Ritter Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to Ritter Pharmaceuticals, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,785,160 | Prebiotic Formulations and Methods of Use Lapsed on the fee record Ended Jul 22, 2026 · Medium confidence | Lapsed on the fee record | Ended Jul 22, 2026 | Medium confidence |
| US 9,808,481 | Prebiotic formulations and methods of use Lapsed on the fee record Ended Nov 7, 2025 · From the USPTO record | Lapsed on the fee record | Ended Nov 7, 2025 | From the USPTO record |
| US 9,775,860 | Prebiotic formulations and methods of use Lapsed on the fee record Ended Oct 3, 2025 · From the USPTO record | Lapsed on the fee record | Ended Oct 3, 2025 | From the USPTO record |
| US 8,492,124 | Prebiotic Formulations and Methods of Use Lapsed on the fee record Ended Jul 23, 2025 · Medium confidence | Lapsed on the fee record | Ended Jul 23, 2025 | Medium confidence |
| US 8,486,668 | Prebiotic Formulations and Methods of Use Lapsed on the fee record Ended Jul 16, 2025 · Medium confidence | Lapsed on the fee record | Ended Jul 16, 2025 | Medium confidence |
| US 11,028,422 | Process for the production of ultrapure galacto-oligosaccharides Lapsed on the fee record Ended Jun 8, 2025 · From the USPTO record | Lapsed on the fee record | Ended Jun 8, 2025 | From the USPTO record |
| US 9,592,248 | Prebiotic Formulations and Methods of Use Lapsed on the fee record Ended Mar 14, 2025 · Medium confidence | Lapsed on the fee record | Ended Mar 14, 2025 | Medium confidence |
| US 9,579,340 | Prebiotic formulations and methods of use Lapsed on the fee record Ended Feb 28, 2025 · From the USPTO record | Lapsed on the fee record | Ended Feb 28, 2025 | From the USPTO record |
| US 9,370,532 | Prebiotic formulations and methods of use Lapsed on the fee record Ended Jun 21, 2024 · From the USPTO record | Lapsed on the fee record | Ended Jun 21, 2024 | From the USPTO record |
| US 9,226,933 | Methods and compositions for treating lactose intolerance Lapsed on the fee record Ended Jan 5, 2024 · From the USPTO record | Lapsed on the fee record | Ended Jan 5, 2024 | From the USPTO record |